Clinical Trial Update: Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating treatment with human umbilical cord mesenchymal stem cells for refractory diabetic peripheral neuropathy (type 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Wuhan Central Hospital | Conditions: Diabetic Peripheral Neuropathy Type 2 | Phase 1, Phase 2 | Status: UNKNOWN